Neuroblastoma — Trials

Neuroblastoma — Trials · CancerIndex

Clinical trials

Registered studies

616 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 137
Recruiting: 75
Ph III recruiting: 8
Growth YoY: −28%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (80)

clinicaltrialsPublishedShowing 601–616 of 616 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00608452	Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers	completed	—	121	Memorial Sloan Kettering Cancer CenterOTHER	1	Nov 13, 2009	clinicaltrials
NCT00730444	Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma	approved for marketing	—	—	GE HealthcareINDUSTRY	1	Nov 9, 2009	clinicaltrials